Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to www.corbuspharma.com
Corbus Pharmaceuticals Holdings, Inc. IR Overview
  • Investors
  • Presentations
  • Analyst Coverage
  • News / Events
    • Press Releases
    • Events
  • Company Information
    • Profile
    • IR Contacts
    • FAQ
  • Financial Information
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • chevron_leftBack to www.corbuspharma.com

Press Releases

News / Events

News / Events

  • Press Releases
  • Events
Jun 30, 2025 • 8:00 am EDT
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
Jun 25, 2025 • 8:00 am EDT
Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
Jun 24, 2025 • 4:05 pm EDT
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
May 22, 2025 • 8:00 am EDT
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 19, 2025 • 8:00 am EDT
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair
May 8, 2025 • 8:00 am EDT
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference
May 6, 2025 • 8:00 am EDT
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Mar 28, 2025 • 8:00 am EDT
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
Mar 11, 2025 • 8:00 am EDT
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
Feb 25, 2025 • 8:00 am EST
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Corbus Pharmaceuticals Holdings, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement